All In Biotech

NDA 018037 · Baxter Hlthcare

Dextrose 5%, Sodium Chloride 0.2% and Potassium Chloride 20meq

Dextrose, Potassium Chloride, Sodium Chloride · Injection

Last checked: Nov 20, 2026Latest source record: Feb 21, 2019 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1979

Feb 2, 1979

Approved uses

1

Original approval plus efficacy supplements

Registered trials

3,797

712 Phase 3, 359 recruiting

FAERS reports

11

4 serious, 0 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Feb 21, 2019.

Potassium Chloride in Dextrose and Sodium Chloride Injection is indicated as a source of water, electrolytes and calories. Potassium Chloride in Dextrose and Sodium Chloride Injection is indicated as a source of water, electrolytes and calories. ( 1 )

Mechanism: Potassium Chloride in Dextrose and Sodium Chloride Injection is a source of water, electrolytes and calories. It is capable of inducing diuresis depending on the clinical condition of the patient.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Feb 2, 1979 Original approval · Type 5 - New Formulation or New Manufacturer
9 products under this application
  • DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ · DEXTROSE 5GM/100ML; POTASSIUM CHLORIDE 150MG/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ · DEXTROSE 5GM/100ML; POTASSIUM CHLORIDE 75MG/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K) · DEXTROSE 5GM/100ML; POTASSIUM CHLORIDE 224MG/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ · DEXTROSE 5GM/100ML; POTASSIUM CHLORIDE 75MG/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ · DEXTROSE 5GM/100ML; POTASSIUM CHLORIDE 300MG/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ · DEXTROSE 5GM/100ML; POTASSIUM CHLORIDE 150MG/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ · DEXTROSE 5GM/100ML; POTASSIUM CHLORIDE 224MG/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K) · DEXTROSE 5GM/100ML; POTASSIUM CHLORIDE 150MG/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K) · DEXTROSE 5GM/100ML; POTASSIUM CHLORIDE 300MG/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP

Clinical trials

Interventional ClinicalTrials.gov studies with "Dextrose" as an intervention, any sponsor and status, largest first.

All 3,797 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • blood potassium increased2
  • physical product label issue2
  • product label confusion2
  • product label issue2
  • product packaging confusion2
  • atrial fibrillation1
  • atrial flutter1
  • bradycardia1
  • cardiac arrest1
  • flushing1
  • incorrect product storage1
  • infusion related reaction1

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20141
20152
20161
20172
20213
20222

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 1,414 on PubMed

Sponsor: Baxter Hlthcare · Also marketed as Dextrose 5%, Sodium Chloride 0.2% and Potassium Chloride 10meq, Dextrose 5%, Sodium Chloride 0.2% and Potassium Chloride 15meq (K), Dextrose 5%, Sodium Chloride 0.2% and Potassium Chloride 5meq, Dextrose 5%, Sodium Chloride 0.2% and Potassium Chloride 40meq, Dextrose 5%, Sodium Chloride 0.2% and Potassium Chloride 30meq

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.